Post-Acute Sequelae of Coronavirus-19 (COVID-19) With Dyspnea on Exertion And Associated TaChycardia TrEatment Study

NCT05096884 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Tachycardia
Dyspnea
COVID-19

Interventions

DRUG: Metoprolol Succinate

Sponsor

Hackensack Meridian Health